 There are three cancer therapeutic vaccines which are approved by USA Food and Drug Administration, as following;

Provenge is Sipuleucel-T, a dendritic cell based vaccine for prostate cancer.Bacillus Calmettle-Guerin (TheraCys) is a live attenuated vaccine which makes use of "Mycobacterium bovis" strain for bladder invasive cancer.Talimogene laherparepvec (T-VEC or Imlygic) is a vaccine for advanced oncolytic melanoma